Solving challenges across the cancer care industry
There are a number of key opportunities within the cancer treatment space. At Artera, we approach them in a way that benefits both clinicians and patients.
Artera predicts therapeutic benefit for patients
Using a large volume and a wide variety of clinical data and digital pathology images, our AI-enabled test accomplishes things that conventional techniques and computers cannot do alone.
![Fullwidth Image](https://artera.ai/wp-content/uploads/Multimodal-AI-Architecture-Infographic_V6_03_1661x1528_acf_cropped_1661x1527_acf_cropped-1386x1274.webp)
Shaping the future of cancer treatment decisions
![shaping-the-future](https://artera.ai/wp-content/uploads/ai-in-cancer-alt-scaled-1.webp)
Artera’s unique MMAI architecture can be used to create biomarkers that have the potential to guide personalized treatment decision-making for patients across a variety of cancer types. The growing adoption of digital histopathology will eventually support the global distribution of AI biomarker tests in the future, enabling broad access to therapy personalization.
![Left Icon](https://artera.ai/wp-content/uploads/icon-contact@4x-1-e1689262863580_382x250_acf_cropped_382x250_acf_cropped.png)
Order the ArteraAI
Prostate Test for
your patient.
Start your order
![Right Icon](https://artera.ai/wp-content/uploads/incon-send-to-doc@4x_370x248_acf_cropped.png)